← Back to Search

IN FOCUS for Cancer

N/A

Waitlist Available

Led By Daniel L Hall, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Elevated fear of recurrence (FCRI severity score ≥16)

History of non-metastatic, localized, or regional solid or blood malignancy(ies)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, approximately 2 months, approximately 5 months

Awards & highlights

Study Summary

This trial will test a new, virtual, group mind-body resiliency intervention to see if it can help cancer survivors who are afraid of their cancer coming back.

Eligible Conditions

Cancer
Coping Skills
Coping Behavior

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You have intense fear of the cancer returning (FCRI severity score ≥16).

Select...

You have had cancer before, but it was not spread to other parts of your body.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, approximately 2 months, approximately 5 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, approximately 2 months, approximately 5 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 2 months, approximately 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability: 5 Item Measure of Enjoyableness, Convenience, Helpfulness, Odds of Future Use, and Overall Satisfaction

Feasibility: Retention Rate

Secondary outcome measures

Fear of Cancer Recurrence

Resiliency

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (IN FOCUS)Experimental Treatment1 Intervention

Participants will be randomly assigned and participate in eight weekly virtual group sessions to learn mind-body, cognitive behavioral, and positive psychology skills.

Group II: Usual CareActive Control1 Intervention

Participants will be randomly assigned and receive usual care, which is a referral for virtual group supportive services for cancer survivors provided in the community.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

IN FOCUS

2021

N/A

~70

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Complementary and Integrative Health (NCCIH)NIH

831 Previous Clinical Trials

668,869 Total Patients Enrolled

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,291 Total Patients Enrolled

Daniel L Hall, PhDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the desired outcomes from this research endeavor?

"The overarching purpose of this research, which will be monitored over the timeframe of Baseline to two months, is to measure Acceptability via a 5-point scale. Secondary objectives include evaluating Mind-Body Practice by means of a 17-item questionnaire; Fear of Recurrence with 9 items on the Fear of Cancer Recurrence Inventory severity subscale as well as open questions in an exit interview; and finally, Cancer Related Uncertainty using the 22-item Mishel Uncertainty in Illness Scale - Survivor Version."

Answered by AI

Are there any health care facilities undertaking this research project within city limits?

"Five clinical trial sites offer this medication, including Mass General at Emerson Hospital -- Bethke in Concord; Massachusett General Hospital Cancer Center in Boston; and the Mass General/North Shore Cancer Centre of Danvers."

Answered by AI

Can patients still register for this research experiment?

"According to clinicaltrials.gov, the recruitment period for this study has ended - it was first uploaded on July 9th 2021 and last edited on July 25th 2022. However, there are still 1,538 other medical trials that are currently enrolling patients across the world."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mind-body Resiliency Intervention for Fear of Cancer Recurrence

Daniel Hall 2021. "Mind-body Resiliency Intervention for Fear of Cancer Recurrence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04876599.